ACCÈS RAPIDE AUX LIENS
LAPSER1, also called Leucine zipper putative tumor suppressor 2, is a member of the LZTS family. Due to its deletion in multiple cancers, including prostate tumors, LAPSER1 is purported to be a tumor suppressor. In cancer cell lines, the overexpression of LAPSER1 can lead to growth inhibition and colony-forming efficiency. LAPSER1 is highly expressed in testis and prostate, but can be detected at lower levels in spleen, thymus, uterus, small intestine and colon. LAPSER1 colocalizes with γ-tubulin, MKLP-1 and p80 katanin. LAPSER1 is involved in cytokinesis. The disruption of LAPSER1, which is accompanied by the mislocalization of p80 katanin, results in malformation of the central spindle. This is a potential impetus for carcinogenesis.
Informations pour la commande
Nom du produit | Ref. Catalogue | COND. | Prix HT | QTÉ | Favoris | |
Anticorps LAPSER1 (B-5) | sc-271958 | 200 µg/ml | $316.00 | |||
LAPSER1 (B-5): m-IgG Fc BP-HRP Kit | sc-537712 | 200 µg Ab; 10 µg BP | $354.00 | |||
LAPSER1 (B-5): m-IgGκ BP-HRP Kit | sc-535072 | 200 µg Ab; 40 µg BP | $354.00 | |||
LAPSER1 (B-5): m-IgG1 BP-HRP Kit | sc-545321 | 200 µg Ab; 20 µg BP | $354.00 | |||
LAPSER1 (B-5) peptide neutralisant | sc-271958 P | 100 µg/0.5 ml | $68.00 |